Logo image of AMR

ALPHA METALLURGICAL RESOURCE (AMR) Stock Fundamental Analysis

USA - NYSE:AMR - US0207641061 - Common Stock

153.975 USD
-7.06 (-4.38%)
Last: 10/21/2025, 10:30:02 AM
Fundamental Rating

4

AMR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 155 industry peers in the Metals & Mining industry. AMR has a great financial health rating, but its profitability evaluates not so good. AMR is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

AMR had negative earnings in the past year.
AMR had a positive operating cash flow in the past year.
AMR had positive earnings in 4 of the past 5 years.
AMR had a positive operating cash flow in each of the past 5 years.
AMR Yearly Net Income VS EBIT VS OCF VS FCFAMR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

1.2 Ratios

The Return On Assets of AMR (-1.57%) is comparable to the rest of the industry.
AMR has a Return On Equity of -2.31%. This is comparable to the rest of the industry: AMR outperforms 53.55% of its industry peers.
Industry RankSector Rank
ROA -1.57%
ROE -2.31%
ROIC N/A
ROA(3y)33.45%
ROA(5y)17.86%
ROE(3y)52.85%
ROE(5y)-2.4%
ROIC(3y)N/A
ROIC(5y)N/A
AMR Yearly ROA, ROE, ROICAMR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

1.3 Margins

AMR's Profit Margin has declined in the last couple of years.
AMR's Operating Margin has improved in the last couple of years.
AMR has a Gross Margin (10.43%) which is comparable to the rest of the industry.
AMR's Gross Margin has been stable in the last couple of years.
AMR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.43%
OM growth 3Y-22.8%
OM growth 5Y51.85%
PM growth 3Y-20.84%
PM growth 5YN/A
GM growth 3Y-12.72%
GM growth 5Y0.52%
AMR Yearly Profit, Operating, Gross MarginsAMR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

8

2. Health

2.1 Basic Checks

AMR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AMR has been increased compared to 1 year ago.
Compared to 5 years ago, AMR has less shares outstanding
Compared to 1 year ago, AMR has an improved debt to assets ratio.
AMR Yearly Shares OutstandingAMR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
AMR Yearly Total Debt VS Total AssetsAMR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

AMR has an Altman-Z score of 4.25. This indicates that AMR is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of AMR (4.25) is comparable to the rest of the industry.
AMR has a debt to FCF ratio of 0.03. This is a very positive value and a sign of high solvency as it would only need 0.03 years to pay back of all of its debts.
AMR has a better Debt to FCF ratio (0.03) than 96.13% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that AMR is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.00, AMR is in the better half of the industry, outperforming 78.06% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.03
Altman-Z 4.25
ROIC/WACCN/A
WACC8.97%
AMR Yearly LT Debt VS Equity VS FCFAMR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

AMR has a Current Ratio of 4.06. This indicates that AMR is financially healthy and has no problem in meeting its short term obligations.
AMR has a Current ratio of 4.06. This is in the better half of the industry: AMR outperforms 72.26% of its industry peers.
AMR has a Quick Ratio of 3.21. This indicates that AMR is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of AMR (3.21) is better than 70.32% of its industry peers.
Industry RankSector Rank
Current Ratio 4.06
Quick Ratio 3.21
AMR Yearly Current Assets VS Current LiabilitesAMR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2

3. Growth

3.1 Past

The earnings per share for AMR have decreased strongly by -108.43% in the last year.
Measured over the past years, AMR shows a decrease in Earnings Per Share. The EPS has been decreasing by -1.85% on average per year.
Looking at the last year, AMR shows a very negative growth in Revenue. The Revenue has decreased by -29.63% in the last year.
AMR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.12% yearly.
EPS 1Y (TTM)-108.43%
EPS 3Y-1.85%
EPS 5YN/A
EPS Q2Q%-108.46%
Revenue 1Y (TTM)-29.63%
Revenue growth 3Y9.4%
Revenue growth 5Y8.12%
Sales Q2Q%-31.56%

3.2 Future

Based on estimates for the next years, AMR will show a decrease in Earnings Per Share. The EPS will decrease by -1.55% on average per year.
The Revenue is expected to decrease by -1.61% on average over the next years.
EPS Next Y-118.09%
EPS Next 2Y10.1%
EPS Next 3Y1%
EPS Next 5Y-1.55%
Revenue Next Year-26.19%
Revenue Next 2Y-5%
Revenue Next 3Y-3.34%
Revenue Next 5Y-1.61%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AMR Yearly Revenue VS EstimatesAMR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B
AMR Yearly EPS VS EstimatesAMR Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 20 -20 40 60 80

4

4. Valuation

4.1 Price/Earnings Ratio

AMR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
AMR is valuated reasonably with a Price/Forward Earnings ratio of 8.94.
Based on the Price/Forward Earnings ratio, AMR is valued cheaply inside the industry as 89.68% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 23.18. AMR is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 8.94
AMR Price Earnings VS Forward Price EarningsAMR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AMR is valued a bit cheaper than the industry average as 74.84% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, AMR is valued cheaply inside the industry as 91.61% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 11.55
EV/EBITDA 10.64
AMR Per share dataAMR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.1%
EPS Next 3Y1%

1

5. Dividend

5.1 Amount

With a yearly dividend of 0.73%, AMR is not a good candidate for dividend investing.
AMR's Dividend Yield is a higher than the industry average which is at 2.42.
Compared to an average S&P500 Dividend Yield of 2.34, AMR's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.73%

5.2 History

AMR is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
AMR Yearly Dividends per shareAMR Yearly Dividends per shareYearly Dividends per share 2022 2023 2 4 6

5.3 Sustainability

AMR has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-1.11%
EPS Next 2Y10.1%
EPS Next 3Y1%
AMR Yearly Income VS Free CF VS DividendAMR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

ALPHA METALLURGICAL RESOURCE

NYSE:AMR (10/21/2025, 10:30:02 AM)

153.975

-7.06 (-4.38%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-08 2025-08-08/bmo
Earnings (Next)11-06 2025-11-06/bmo
Inst Owners90.82%
Inst Owner Change-0.88%
Ins Owners5.95%
Ins Owner Change5.74%
Market Cap2.01B
Analysts75
Price Target176.12 (14.38%)
Short Float %12.13%
Short Ratio3.75
Dividend
Industry RankSector Rank
Dividend Yield 0.73%
Yearly Dividend0.24
Dividend Growth(5Y)N/A
DP-1.11%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-29.05%
Min EPS beat(2)-142.85%
Max EPS beat(2)84.75%
EPS beat(4)2
Avg EPS beat(4)-36.7%
Min EPS beat(4)-142.85%
Max EPS beat(4)84.75%
EPS beat(8)4
Avg EPS beat(8)-14.36%
EPS beat(12)5
Avg EPS beat(12)-10.77%
EPS beat(16)8
Avg EPS beat(16)-6.53%
Revenue beat(2)0
Avg Revenue beat(2)-4.45%
Min Revenue beat(2)-8.11%
Max Revenue beat(2)-0.79%
Revenue beat(4)0
Avg Revenue beat(4)-4.95%
Min Revenue beat(4)-8.11%
Max Revenue beat(4)-0.79%
Revenue beat(8)3
Avg Revenue beat(8)0.98%
Revenue beat(12)5
Avg Revenue beat(12)0.43%
Revenue beat(16)9
Avg Revenue beat(16)4.11%
PT rev (1m)3.08%
PT rev (3m)18.67%
EPS NQ rev (1m)-7.75%
EPS NQ rev (3m)-199.54%
EPS NY rev (1m)39.91%
EPS NY rev (3m)6.94%
Revenue NQ rev (1m)0.66%
Revenue NQ rev (3m)-6.8%
Revenue NY rev (1m)-0.27%
Revenue NY rev (3m)-3.25%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.94
P/S 0.85
P/FCF 11.55
P/OCF 6.26
P/B 1.25
P/tB 1.27
EV/EBITDA 10.64
EPS(TTM)-2.85
EYN/A
EPS(NY)17.23
Fwd EY11.19%
FCF(TTM)13.33
FCFY8.65%
OCF(TTM)24.61
OCFY15.98%
SpS181.72
BVpS123.66
TBVpS120.81
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.57%
ROE -2.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 10.43%
FCFM 7.33%
ROA(3y)33.45%
ROA(5y)17.86%
ROE(3y)52.85%
ROE(5y)-2.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)44.94%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-22.8%
OM growth 5Y51.85%
PM growth 3Y-20.84%
PM growth 5YN/A
GM growth 3Y-12.72%
GM growth 5Y0.52%
F-Score5
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.03
Debt/EBITDA 0.02
Cap/Depr 82.69%
Cap/Sales 6.21%
Interest Coverage N/A
Cash Conversion 206.08%
Profit Quality N/A
Current Ratio 4.06
Quick Ratio 3.21
Altman-Z 4.25
F-Score5
WACC8.97%
ROIC/WACCN/A
Cap/Depr(3y)137.43%
Cap/Depr(5y)115.04%
Cap/Sales(3y)5.93%
Cap/Sales(5y)6.47%
Profit Quality(3y)126.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-108.43%
EPS 3Y-1.85%
EPS 5YN/A
EPS Q2Q%-108.46%
EPS Next Y-118.09%
EPS Next 2Y10.1%
EPS Next 3Y1%
EPS Next 5Y-1.55%
Revenue 1Y (TTM)-29.63%
Revenue growth 3Y9.4%
Revenue growth 5Y8.12%
Sales Q2Q%-31.56%
Revenue Next Year-26.19%
Revenue Next 2Y-5%
Revenue Next 3Y-3.34%
Revenue Next 5Y-1.61%
EBIT growth 1Y-104.09%
EBIT growth 3Y-15.54%
EBIT growth 5Y64.18%
EBIT Next Year-35.48%
EBIT Next 3Y24.71%
EBIT Next 5Y31.75%
FCF growth 1Y-81.75%
FCF growth 3Y60.83%
FCF growth 5YN/A
OCF growth 1Y-72.7%
OCF growth 3Y49.12%
OCF growth 5Y34.47%